Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TESARO Inc (NASDAQ:TSRO)

91.99
Delayed Data
As of Jul 22
 -0.05 / -0.05%
Today’s Change
29.51
Today|||52-Week Range
94.01
+75.82%
Year-to-Date
Here's Why Myriad Genetics Is Down 26% in 2016
Jul 21 / MotleyFool.com - Paid Partner Content
Market Momentum Is on the Move
Jul 20 / TheStreet.com - Paid Partner Content
Major Second Quarter Purchases for Cohen Include Tesaro, Pernix
Jul 20 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close92.04
Today’s open92.09
Day’s range91.50 - 93.80
Volume630,667
Average volume (3 months)995,899
Market cap$4.5B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-33.19%
Earnings growth (this year)-11.19%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales6,500.72
Price/Book42.65

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA+0.04+0.24%
NBIXNeurocrine Bioscienc...+0.43+0.88%
ACADACADIA Pharmaceutica...+0.49+1.36%
UTHRUnited Therapeutics ...-1.02-0.91%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)-$1.70
Annual revenue (last year)$317.0K
Annual profit (last year)-$251.4M
Net profit margin-79,308.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Leon O. Moulder
President, Chief Operating Officer &
Director
Mary Lynne Hedley
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs